AXLA Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-01 | Koziel Margaret | officer: Chief Medical Officer | 24,883 | S-Sale | D | 679 | 0.58 | 393.80 |
| 2023-02-17 | Koziel Margaret | officer: Chief Medical Officer | 70,000 | A-Award | A | 70,000 | 0.68 | 47,313.00 |
| 2023-02-17 | Hinshaw William | director, officer: President & CEO | 275,000 | A-Award | A | 275,000 | 0.68 | 185,872.00 |
| 2023-02-17 | Fehlner Paul | officer: SVP & Chief Legal Officer | 70,000 | A-Award | A | 70,000 | 0.68 | 47,313.00 |
| 2023-02-10 | Fehlner Paul | officer: SVP & Chief Legal Officer | 58,081 | S-Sale | A | 5,221 | 0.66 | 3,447.00 |
| 2022-11-16 | NISSEN TORBEN STRAIGHT | director | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2022-11-16 | Rosiello Robert L. | director | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2022-10-17 | Hinshaw William | officer: President & CEO | 98,012 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2022-10-19 | Hinshaw William | officer: President & CEO | 82,012 | S-Sale | D | 16,000 | 1.56 | 25,027.00 |
| 2022-10-13 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 14,101,638 | P-Purchase | A | 2,757,333 | 1.64 | 4,522,026.00 |
| 2022-10-13 | AFEYAN NOUBAR | director | 14,101,638 | P-Purchase | A | 2,757,333 | 1.64 | 4,522,026.00 |
| 2022-10-13 | AFEYAN NOUBAR | director | 11,344,305 | P-Purchase | A | 2,743,902 | 1.64 | 4,499,999.00 |
| 2022-10-13 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 11,344,305 | P-Purchase | A | 2,743,902 | 1.64 | 4,499,999.00 |
| 2022-10-13 | AFEYAN NOUBAR | director | 6,299,611 | P-Purchase | A | 919,111 | 1.64 | 1,507,342.00 |
| 2022-10-13 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 6,299,611 | P-Purchase | A | 919,111 | 1.64 | 1,507,342.00 |
| 2022-10-13 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 5,380,500 | P-Purchase | A | 914,634 | 1.64 | 1,500,000.00 |
| 2022-10-13 | AFEYAN NOUBAR | director | 5,380,500 | P-Purchase | A | 914,634 | 1.64 | 1,500,000.00 |
| 2022-10-13 | AFEYAN NOUBAR | director | 3,048,780 | P-Purchase | A | 3,048,780 | 1.64 | 4,999,999.00 |
| 2022-10-13 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 3,048,780 | P-Purchase | A | 3,048,780 | 1.64 | 4,999,999.00 |
| 2022-10-13 | Flagship Pioneering Inc. | director | 3,048,780 | I | 0 | 0.00 | 0.00 | |
| 2022-10-10 | Rosiello Robert L. | None | 0 | None | None | 0.00 | ||
| 2022-10-10 | Rosiello Robert L. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-10-10 | NISSEN TORBEN STRAIGHT | None | 0 | None | None | 0.00 | ||
| 2022-10-10 | NISSEN TORBEN STRAIGHT | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-10-13 | NESTLE SA | director | 11,105,438 | P-Purchase | A | 3,658,536 | 1.64 | 5,999,999.00 |
| 2022-10-13 | Societe des Produits Nestle S.A. | 10 percent owner | 11,105,438 | P-Purchase | A | 3,658,536 | 1.64 | 5,999,999.00 |
| 2022-05-19 | Epstein David R | director: | 209,756 | A-Award | A | 47,059 | 0.00 | 0.00 |
| 2022-06-01 | Koziel Margaret | officer: Chief Medical Officer | 26,109 | S-Sale | D | 590 | 2.01 | 1,186.00 |
| 2022-05-19 | SEKHRI PAUL J | director: | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2022-05-19 | SEKHRI PAUL J | director | 40,000 | A-Award | A | 40,000 | 1.70 | 68,000.00 |
| 2022-05-19 | SEKHRI PAUL J | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-19 | Hendrix Martin | director: | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2022-05-19 | Hendrix Martin | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-05-19 | Sohn Catherine A. | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-05-19 | Sohn Catherine A. | director | 20,000 | A-Award | A | 20,000 | 1.70 | 34,000.00 |
| 2022-05-19 | Baird William D III | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-05-19 | Baird William D III | director | 20,000 | A-Award | A | 20,000 | 1.70 | 34,000.00 |
| 2022-05-19 | Rondinone CRISTINA | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-05-19 | Rondinone CRISTINA | director | 20,000 | A-Award | A | 20,000 | 1.70 | 34,000.00 |
| 2022-05-19 | Pisano Gary P. | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-05-19 | Rosenblatt Michael | director: | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2022-05-19 | Rosenblatt Michael | director | 40,000 | A-Award | A | 40,000 | 1.70 | 68,000.00 |
| 2022-05-19 | Rosenblatt Michael | director | 3,053 | D | 0 | 0.00 | 0.00 | |
| 2022-05-19 | Rosenblatt Michael | director | 0 | D | 3,732 | 6.52 | 24,333.00 | |
| 2022-05-19 | Rosenblatt Michael | director | 0 | D | 4,071 | 6.21 | 25,281.00 | |
| 2022-05-19 | Rosenblatt Michael | director | 0 | D | 5,428 | 13.83 | 75,069.00 | |
| 2022-03-17 | Epstein David R | director: | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2022-03-17 | Epstein David R | director: | 0 | M-Exempt | D | 1,535 | 0.00 | 0.00 |
| 2022-03-16 | Crane Robert | officer: Chief Financial Officer | 125,000 | A-Award | A | 125,000 | 0.00 | 0.00 |
| 2022-03-16 | Hinshaw William | officer: President & CEO | 48,012 | P-Purchase | A | 13,089 | 1.91 | 25,000.00 |
| 2022-03-16 | Fehlner Paul | officer: SVP & Chief Legal Officer | 20,802 | P-Purchase | A | 10,471 | 1.91 | 20,000.00 |
| 2022-03-16 | Epstein David R | director: | 161,162 | P-Purchase | A | 26,178 | 1.91 | 50,000.00 |
| 2022-03-16 | Crane Robert | officer: Chief Financial Officer | 39,267 | P-Purchase | A | 39,267 | 1.91 | 75,000.00 |
| 2022-03-16 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 8,600,403 | P-Purchase | A | 3,791,623 | 1.91 | 7,242,000.00 |
| 2022-03-16 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 4,465,866 | P-Purchase | A | 1,579,843 | 1.91 | 3,017,500.00 |
| 2022-03-16 | AFEYAN NOUBAR | director: | 4,465,866 | P-Purchase | A | 1,579,843 | 1.91 | 3,017,500.00 |
| 2022-03-16 | Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2,004,657 | P-Purchase | A | 947,905 | 1.91 | 1,810,499.00 |
| 2022-03-16 | NESTLE SA | director: | 7,446,902 | P-Purchase | A | 3,141,361 | 1.91 | 6,000,000.00 |
| 2022-03-16 | Societe des Produits Nestle S.A. | 10 percent owner | 7,446,902 | P-Purchase | A | 3,141,361 | 1.91 | 6,000,000.00 |
| 2022-03-01 | Koziel Margaret | officer: Chief Medical Officer | 26,699 | S-Sale | D | 553 | 1.86 | 1,030.00 |
| 2022-02-08 | Crane Robert | officer: Chief Financial Officer | 0 | D | 200,000 | 1.63 | 326,000.00 | |
| 2022-02-18 | Epstein David R | director | 134,984 | M-Exempt | A | 1,534 | 0.00 | 0.00 |
| 2022-02-18 | Epstein David R | director | 1,535 | M-Exempt | D | 1,534 | 0.00 | 0.00 |
| 2022-02-08 | Schecter Alison D. | officer: President - Research & Dev. | 56,000 | A-Award | A | 56,000 | 1.63 | 91,280.00 |
| 2022-02-08 | Fehlner Paul | officer: SVP & Chief Legal Officer | 70,000 | A-Award | A | 70,000 | 1.63 | 114,100.00 |
| 2022-02-08 | Hinshaw William | director, officer: President & CEO | 275,000 | A-Award | A | 275,000 | 1.63 | 448,250.00 |
| 2022-02-08 | Hinshaw William | director, officer: President & CEO | 100,000 | A-Award | A | 100,000 | 5.00 | 500,000.00 |
| 2022-02-08 | Koziel Margaret | officer: Chief Medical Officer | 33,397 | A-Award | A | 33,397 | 1.63 | 54,437.00 |
| 2022-02-08 | Dean Virginia R | officer: SVP, Chief People Officer | 71,400 | A-Award | A | 71,400 | 1.63 | 116,382.00 |
| 2022-01-28 | Hinshaw William | director, officer: President and CEO | 50,000 | M-Exempt | A | 50,000 | 0.00 | 0.00 |
| 2022-01-31 | Hinshaw William | director, officer: President and CEO | 33,410 | S-Sale | D | 16,590 | 1.65 | 27,393.00 |
| 2022-01-28 | Hinshaw William | director, officer: President and CEO | 0 | M-Exempt | D | 50,000 | 0.00 | 0.00 |
| 2022-01-18 | Epstein David R | director | 133,450 | M-Exempt | A | 1,535 | 0.00 | 0.00 |
| 2022-01-18 | Epstein David R | director | 3,069 | M-Exempt | D | 1,535 | 0.00 | 0.00 |
| 2021-12-17 | Epstein David R | director | 131,915 | M-Exempt | A | 1,535 | 0.00 | 0.00 |
| 2021-12-17 | Epstein David R | director | 4,604 | M-Exempt | D | 1,535 | 0.00 | 0.00 |
| 2021-12-10 | Schecter Alison D. | officer: President - Research & Dev. | 25,000 | A-Award | A | 25,000 | 5.57 | 139,250.00 |
| 2021-12-10 | Koziel Margaret | officer: Chief Medical Officer | 75,000 | A-Award | A | 75,000 | 2.60 | 195,000.00 |
| 2021-12-01 | Koziel Margaret | officer: Chief Medical Officer | 30,000 | D | 0 | 0.00 | 0.00 | |
| 2021-12-01 | Koziel Margaret | officer: Chief Medical Officer | 0 | D | 20,800 | 9.31 | 193,648.00 | |
| 2021-12-01 | Koziel Margaret | officer: Chief Medical Officer | 0 | D | 10,250 | 4.12 | 42,230.00 | |
| 2021-12-01 | Koziel Margaret | officer: Chief Medical Officer | 0 | D | 11,000 | 5.04 | 55,440.00 | |
| 2021-12-01 | Koziel Margaret | officer: Chief Medical Officer | 0 | D | 31,050 | 6.59 | 204,620.00 | |
| 2021-12-01 | Koziel Margaret | officer: Chief Medical Officer | 0 | D | 10,000 | 4.11 | 41,100.00 | |
| 2021-11-18 | Epstein David R | director | 130,380 | M-Exempt | A | 1,534 | 0.00 | 0.00 |
| 2021-11-18 | Epstein David R | director | 6,139 | M-Exempt | D | 1,534 | 0.00 | 0.00 |
| 2021-10-18 | Epstein David R | director | 128,846 | M-Exempt | A | 1,535 | 0.00 | 0.00 |
| 2021-10-18 | Epstein David R | director | 7,673 | M-Exempt | D | 1,535 | 0.00 | 0.00 |
| 2021-09-17 | Epstein David R | director | 127,311 | M-Exempt | A | 1,535 | 0.00 | 0.00 |
| 2021-09-17 | Epstein David R | director | 9,208 | M-Exempt | D | 1,535 | 0.00 | 0.00 |
| 2021-08-13 | Pisano Gary P. | director | 81,433 | M-Exempt | A | 81,433 | 0.28 | 22,801.00 |
| 2021-08-13 | Pisano Gary P. | director | 0 | M-Exempt | D | 81,433 | 0.28 | 22,801.00 |
| 2021-08-18 | Epstein David R | director | 125,776 | M-Exempt | A | 1,534 | 0.00 | 0.00 |
| 2021-08-18 | Epstein David R | director | 10,743 | M-Exempt | D | 1,534 | 0.00 | 0.00 |
| 2021-07-16 | Epstein David R | director | 124,242 | M-Exempt | A | 1,535 | 0.00 | 0.00 |
| 2021-07-16 | Epstein David R | director | 12,277 | M-Exempt | D | 1,535 | 0.00 | 0.00 |
| 2021-06-22 | Dean Virginia R | officer: SVP, Chief People Officer | 140,000 | A-Award | A | 140,000 | 4.15 | 581,000.00 |
| 2021-06-21 | Dean Virginia R | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2021-06-18 | Epstein David R | director | 122,707 | M-Exempt | A | 1,535 | 0.00 | 0.00 |
| 2021-06-18 | Epstein David R | director | 13,812 | M-Exempt | D | 1,535 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
